Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfectionFloriane Gallais, Samira Fafi‐Kremer, de Sèze et al.|EBioMedicine|2021Cited by 239
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2Ludivine Grzelak, Samira Fafi‐Kremer, de Sèze et al.|The Journal of Infectious Diseases|2021Cited by 85
Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC StudyOdile Launay, David Rey, Corinne Desaint et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2008Cited by 71